Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Expenses data on file, last reported at $30.4 million in Q3 2025.

• Quarterly Operating Expenses rose 4.42% year-over-year to $30.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $93.4 million (down 22.01% YoY) and the FY2024 annual result came in at $119.7 million, up 6.23% from the prior year.
• Operating Expenses declined to $30.4 million in Q3 2025 per LUNG's latest filing, from $32.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $32.0 million in Q2 2025 and bottomed at $19.1 million in Q1 2021.
• The 5-year median for Operating Expenses is $28.2 million (2023), against an average of $26.7 million.
• The widest annual swing landed in 2021, when Operating Expenses jumped 73.16%; it then grew 3.37% in 2024.
• Tracing LUNG's Operating Expenses over 5 years: stood at $22.6 million in 2021, then grew by 14.12% to $25.8 million in 2022, then gained by 9.72% to $28.3 million in 2023, then increased by 9.49% to $31.0 million in 2024, then slipped by 1.81% to $30.4 million in 2025.
• Per Business Quant, the three latest LUNG Operating Expenses figures stand at $30.4 million (Q3 2025), $32.0 million (Q2 2025), and $30.9 million (Q1 2025).

Peer Comparison